International Stem Cell Corporation Announces Third Patient with Parkinson’s Disease in Phase I Clinical Trial – P&T Community

Posted: March 5, 2017 at 6:41 pm

International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial
P&T Community
28, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced the third patient in the clinical trial ...

and more »

Read the original post:
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial - P&T Community

Related Posts

Comments are closed.

Archives